Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05953090 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Study acronym: VALOR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jun 2026 to Jun 2028
    • Study sites: 12 to 14
    • Study completion date: Dec 2026 to Dec 2028
    v6
  2. Site contacts updated at 10 of 12 sitesv5
  3. Site details revised at 6 of 12 sitesv4
  4. Study sites: 2 to 12v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Oct 2023 to Oct 30, 2023
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Trial Details
NCT Number NCT05953090
Lead Sponsor Stratpharma AG
Conditions
(from sponsor)		 Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
Related terms Atrophic Vaginitis, Vulvar Lichen Sclerosus
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov